Published November 6, 2024 | Version 1
Dataset Open

SHOCK Trial - Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock

  • 1. ROR icon NYU Langone Health

Contributors

Description

The leading cause of death in patients hospitalized for acute myocardial infarction is cardiogenic shock. We conducted a randomized trial to evaluate early revascularization in patients with cardiogenic shock. In patients with cardiogenic shock, emergency revascularization did not significantly reduce overall mortality at 30 days. However, after six months there was a significant survival benefit. Our conclusion was that early revascularization should be strongly considered for patients with acute myocardial infarction complicated by cardiogenic shock. We are making original data that was collected for this trial available here for further analysis.

Abstract (English)

Although the SHOCK trial[1] was completed decades ago, it is a unique and valuable dataset. There was a publication[2] using these data a few years ago and a recent proposal using these data was sent to the principal investigators of the original study.  Other analyses have been reported well after the NHLBI grant-funded project ended [7, 8, 9]

Cardiogenic shock complicates 7 to 10 percent of cases of acute myocardial infarction and is associated with a 70 to 80 percent mortality rate[3]. Cardiogenic shock remains the leading cause of death in patients hospitalized with myocardial infarction in the reperfusion era[4]. Nonrandomized studies report markedly lower mortality rates among patients who have undergone re-vascularization for shock. However, selection bias is evident. In small series of patients undergoing early primary angioplasty for cardiogenic shock, in-hospital mortality rates ranged from 26 percent to 72 percent[5]. A prematurely terminated randomized trial comparing angioplasty with conventional therapy for shock in 55 patients reported no difference in mortality.

Prior to this trial and the new national guideline recommendations, most patients with cardiogenic shock did not undergo emergency revascularization, either because of the lack of facilities at the hospitals where they present or because of doubt as to its efficacy. Early revascularization (angioplasty or coronary-artery bypass graft surgery) is now a Class I recommendation: it reduces mortality, and should be performed on an urgent basis, even if this requires transfer to a hospital with the necessary facilities and expertise. Community studies show that use has increased and is associated with concomitant reduction in mortality.

Patients with shock due to left ventricular failure complicating myocardial infarction were randomly assigned to emergency revascularization (152 patients) or initial medical stabilization (150 patients). Revascularization was accomplished by either coronary-artery bypass grafting or angioplasty. Intraaortic balloon counterpulsation was performed in 86 percent of the patients in both groups. The primary end point was mortality from all causes at 30 days. Six-month survival was a secondary end point. Screened patients with suspected cardiogenic shock due to AMI that were ineligible or did not consent were entered in a registry. The SHOCK Trial demonstrated that emergency revascularization reduced all-cause mortality by 13% absolute percentage at 6 months, which was durable in long-term follow-up [1, 10]

Data were entered by participating sites into a structured database housed at NERI (now HealthCore).

The dataset made available here has been deidentified using the 'safe harbor' approach. All patient identifiers were removed, all dates were rolled up to only indicate the year. A unique ID number was created for each patient for the purposes of linking patients between files. There are no patients in the dataset with age >90.

Table of contents (English)

There are 3 classes of documents in the dataset:

  • Data - raw data files
    • trail_deident.csv 
    • echo_deident.csv
    • survival_deident.csv
  • Codebooks - dictionaries for columns and choices within columns
    • TrlArchive2005Contents.pdf - dictionary of column names with description of columns for trial_deident.csv
    • echo_code.pdf - dictionary of column names with description of columns for echo_deident.csv
    • SurvivalContents.pdf -  dictionary of column names with description of columns for survival_deident.csv
    • formats.txt - code translation for values chosen in columns in the data files
  • Templates - case report forms used in the original trial that contain the data that was summarized in trial_deident.csv and echo_deident.csv
    • FORM01.DOC - trial_deident.csv
    • FORM02.DOC - trial_deident.csv
    • FORM04.DOC - trial_deident.csv
    • FORM05.DOC - trial_deident.csv
    • FORM08A.DOC - trial_deident.csv
    • FORMS1.DOC - trial_deident.csv
    • FORMS3.DOC - trial_deident.csv
    • FORM09A.DOC - echo_deident.csv

Files

echo_deident.csv

Files (2.5 MB)

Name Size Download all
md5:9de315bdffcbd878e0fdc4264fc1c436
207.0 kB Preview Download
md5:05154ed576f2d4211250201304705257
432.5 kB Preview Download
md5:ea4ed09fc83cfdb2a9c29c9f5c4a822b
102.4 kB Download
md5:66d18a338e6a47af4a6207ea70ad4725
35.8 kB Download
md5:d382da9aa87afc0c790aa5c965611c94
179.7 kB Download
md5:a65c590e8e4e54ef339f25baf3547709
255.5 kB Download
md5:82bceeef440810838ca977447b3f2194
233.0 kB Download
md5:88d57810bc655d6e975443999c8d8bde
60.9 kB Download
md5:a931c5594b26479da38a2bc8d0e1dd16
4.1 kB Preview Download
md5:fe106771edd26a3edbe57f08f173eb99
60.9 kB Download
md5:0558320fb17691a194c2a82d2ebf3673
43.0 kB Download
md5:3637c81eccec742eef13d37920e57c2a
65.5 kB Preview Download
md5:d149e8fe3722b033850488ca3214f07c
35.9 kB Preview Download
md5:ef8d0e8d5d0c040ea8b5ac7b01557305
553.5 kB Preview Download
md5:746a25704c1b205add1ec611ec11c99c
218.0 kB Preview Download

Additional details

Related works

Is source of
Publication: 10460813 (PMID)

References

  • Lala A et al. Right Ventricular Dysfunction in Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Hemodynamic Analysis of the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) Trial and Registry. J Card Fail. 2018 Mar;24(3):148-156.
  • Goldberg RJ, Gore JM, Alpert JS, et al. Cardiogenic shock after acute myocardial infarction: incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 1991;325:1117-1122
  • Holmes DR Jr, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. J Am Coll Cardiol 1995;26:668-674
  • Antoniucci D, Valenti R, Santoro GM, et al. Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J Am Coll Cardiol 1998;31:294-300
  • Urban P, Stauffer JC, Bleed D, et al. A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction: the (Swiss) multicenter trial of angioplasty for shock -- (S)MASH. Eur Heart J 1999;20:1030-1038
  • Bangalore S, Gupta N, Guo Y, Lala A, Balsam L, Roswell RO, Reyentovich A, Hochman JS, Outcomes with Invasive versus Conservative Management of Cardiogenic Shock Complicating Acute Myocardial Infarction, The American Journal of Medicine 2015 Jun;128(6):601-8
  • Jeger R, Urban P, Harkness S, Tseng CH, Stauffer JC, LeJemtel TH, Sleeper L, Pfisterer ME, Hochman JS.  Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials.  Acute Cardiac Care 2011; 13(1): 14-20
  • Lee MS, Tseng CH, Barker CM, Menon V, Steckman D, Shemin R, and Hochman JS. Outcome following Surgery and Percutaneous Intervention for Cardiogenic Shock and Left Main Disease. Ann Thoracic Surgery 2008;86(1):29-34
  • Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, Col J, White HD.  "Early Revascularization Improves Long-Term Survival for Cardiogenic Shock Complicating Acute Myocardial Infarction."  JAMA 2006; 295:2511-2515